CEO Dr. Mark Day of Bioasis Technologies Inc. (OTCQB: BIOAF)

from Stock Day Media · host Stock Day Media

CEO Dr. Mark Day of Bioasis Technologies Inc. (OTCQB: BIOAF), joins Stock Day to give details on developing xB3 for treatment of brain cancer and neurodegenerative disease. OTCQB: BIOAF # biopharmaceutical company developing xB3 # proprietary platform technology # disease-modifying treatments # Alzheimer’s and Huntington’s # blood-brain barrier (BBB) # brain cancers and neurodegenerative diseases # Canada # Glioblastoma # Parkinson’s # treatment of CNS disorders # Vancouver Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published May 29, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

CEO Dr. Mark Day of Bioasis Technologies Inc. (OTCQB: BIOAF)

0:00 16:06

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 16 minutes long.

When was this Stock Day Media episode published?

This episode was published on May 29, 2018.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!